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Satisfaction with Intrauterine Device Insertion Procedure Among
Adolescent and Young Adult Women in a Clinical Trial
Abstract
OBJECTIVE:

To evaluate satisfaction with intrauterine device (IUD) insertion procedures among adolescent and young
adult women.
METHODS:

This secondary analysis of data from a multisite, single-blind, sham-controlled randomized trial of women
having a levonorgestrel 13.5-mg IUD inserted enrolled participants from March 2015 through July 2016 at
three family planning clinics in Philadelphia, Pennsylvania. Eligible participants were 14-22 years of age,
nulliparous, not pregnant, and English-speaking. Randomization was computer-generated allocation in block
sizes of four to a 1% lidocaine paracervical or sham block. Only patients were blinded. Satisfaction was
measured with three items that assessed overall satisfaction with the procedure, whether participants would
recommend the IUD to a friend, and the perception that the IUD was worth the discomfort. Predictors
included demographics, sexual and reproductive history, pain after IUD insertion, and treatment group.
RESULTS:

Ninety-five women enrolled; 93 (97.9%) were included in the analysis. Forty-five (47.4%) were white, 34
(36.0%) were black, 62 (66.0%) were privately insured, and 75 (79.0%) had used contraception previously.
Most (n=73 [76.8%]) reported high overall satisfaction with the procedure, 64 (67.4%) would recommend an
IUD to a friend, and 79 (83.2%) perceived the IUD was worth the discomfort. The odds of reporting high
overall satisfaction were lower among adolescents compared with young adults (odds ratio [OR] 0.07, 95% CI
0.008-0.68); those who never had a gynecologic examination compared with those who had (OR 0.26, 95%
CI 0.07-0.99); and decreased as pain score increased (OR 0.96, 95% CI 0.94-0.99). Higher pain scores were
negatively correlated with the odds of recommending an IUD to a friend and perceiving the IUD was worth
the discomfort.
CONCLUSION:

Adolescent and young adult women report high levels of satisfaction after the IUD insertion procedure. Young
age, lack of experience with gynecologic examinations, and high pain were inversely related to satisfaction.
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Abstract
OBJECTIVE—To evaluate satisfaction with intrauterine device (IUD) insertion procedures
among adolescent and young adult women.

Author Manuscript

METHODS—This secondary analysis of data from a multisite, single-blind, sham-controlled
randomized trial of women having a levonorgestrel 13.5 mg IUD inserted enrolled participants
from March 2015 through July 2016 at 3 family planning clinics in Philadelphia, Pennsylvania.
Eligible women were 14 to 22 years, nulliparous, not pregnant, and English speaking.
Randomization was via computer generated allocation in block sizes of 4 to a 1% lidocaine
paracervical or sham block. Only patients were blinded. Satisfaction was measured with 3-items
that assessed overall satisfaction with the procedure, whether participants would recommend the
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IUD to friend, and the perception that the IUD was worth the discomfort. Predictors included
demographics, sexual and reproductive history, pain following IUD insertion, and treatment group.
RESULTS—Ninety-five women enrolled; 93 (97.9%) were included in the analysis. Forty-five
(47.4%) were white, 34 (36.0%) were black, 62 (66.0%) privately insured, and 75 (79.0%)
previously used contraception. Most (n=71, 76.8%) reported high overall satisfaction with the
procedure, 62 (67.4%) would recommend an IUD to a friend, and 77 (83.2%) perceived the IUD
was worth the discomfort. The odds of reporting high overall satisfaction were lower among
adolescents compared to young adults (OR 0.07, 95% CI: 0.008, 0.68); those who never had a
gynecologic exam compared to those who had (OR 0.26; 95% CI: 0.069, 0.99); and decreased as
pain score increased (OR 0.96; 95% CI: 0.94, 0.99). Higher pain scores were negatively correlated
with the odds of recommending an IUD to a friend and perceiving the IUD was worth the
discomfort.

Author Manuscript

CONCLUSION—Adolescent and young adult women report high levels of satisfaction following
the IUD insertion procedure. Young age, lack of experience with gynecologic exams, and high
pain were inversely related to satisfaction.
Clinical Trial Registration—ClinicalTrials.gov, https://clinicaltrials.gov, NCT02352714.

INTRODUCTION

Author Manuscript

Although intrauterine devices (IUDs) have been available in the U.S. for decades, utilization
rates remain low among adolescent and young adult women. Only 4% use IUDs compared
to 12% of women over age 20 years.2–4 The contraceptives most commonly used by young
women (pills, patch, and ring) are twenty times less effective than IUDs.5,6 Given the high
rate of unintended pregnancies in this population, improving IUD use is important.5,6
Barriers to IUD utilization including lack of knowledge, negative personal attitudes, negative
social norms, and limited IUD access, particularly in pediatric care settings.7–9 Interventions
have focused on improving access, promoting patient-centered counseling, and promoting
long-acting methods.10,11

Author Manuscript

An understudied aspect of IUD utilization is women’s perceptions of the IUD insertion
procedure. For young women, concern about discomfort during the insertion procedure is a
major barrier to IUD use. Improving our understanding of young women’s experiences
during the procedure may aid with counseling and service delivery, help address preprocedure anxiety, identify modifiable aspects of the procedure, and improve IUD uptake.
7–9,12 Studies assessing young women’s satisfaction with the IUD measure satisfaction six to
12 months after device placement; we are not aware of any studies assessing young women’s
satisfaction immediately following IUD insertion.13–15 In the current study, we examine
satisfaction with the IUD insertion procedure and predictors of satisfaction among
adolescent and young adult women participating in a randomized clinical trial that examined
the effectiveness of a 1% lidocaine paracervical nerve block on pain reported during IUD
insertion compared to a sham block.
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MATERIALS AND METHODS
Study Design

Author Manuscript

This was a secondary analysis of data from a multisite, single-blind, sham-controlled
randomized trial conducted at three clinics in Philadelphia, Pennsylvania from March 2015
to July 2016 that involved one study visit. The CONSORT guidelines were followed to
design and report the trial; full details regarding the trial are repored elsewhere.16 The
protocol is available by request. Institutional Review Board (IRB) approval was obtained
from the Children’s Hospital of Philadelphia (CHOP, which was the IRB of record),
Hospital of the University of Pennsylvania, and Thomas Jefferson University, all of which
performed study visits. Approval was also obtained from AccessMatters, which funds Title
X clinics in southeastern Pennsylvania, which allowed study recruitment flyers to be posted
in Title X clinics that refer adolescents to CHOP for IUD insertions. The trial was registered
with Clinical trials.gov (NCT# NCT02352714).
Recruitment, Eligibility and Consent

Author Manuscript

Women presenting to a study site requesting a hormonal IUD were asked by a clinician if
they were interested in talking with research staff about the study. Interested women seeking
reproductive health services at a non-enrolling study site who saw a recruitment flyer called
the study coordinator who described the study and scheduled a study visit. Patients were
eligible for inclusion if they were between ages 14 to 22 years, nulliparous, not pregnant
currently, not pregnant in the prior 6 weeks, interested in the Skyla IUD (levonorgestrel
13.5mg IUD), and English speaking. The cut-off of 22 years, rather than 24 years, was
chosen to minimize the number of older, young adult women. Patients were excluded if they
did not meet medical eligibility criteria for an IUD;17 had a contraindication to taking
amino-amide anesthetics or non-steroidal anti-inflammatory agents; were unwilling to be
randomized; were at high risk for pregnancy; used narcotics or benzodiazepine in the prior
24 hours; previously used an IUD; or had a prior unsuccessful IUD insertion. Women could
enroll at a later date if inclusion criteria were not initially met. Written informed consent
was obtained from all participants, regardless of age, since females 13 and older in
Pennsylvania can legally consent for reproductive services and research studies regarding
reproductive services, and because requiring parental permission for study participation
would have compromised confidentiality.
Trial Procedures and Treatment Group Description

Author Manuscript

Participants completed a questionnaire assessing demographic characteristics and their
medical and reproductive history. Prior to randomization, participants received 800 mg of
ibuprofen orally at least 20 minutes prior to the procedure to reduce post-procedure pain.18
Randomization was performed by a research coordinator in the Research Data Capture
(REDCap) software in block sizes of 4 with stratification by age (14 – 17 or 18 – 22 years),
race, and recruitment site after completion of the demographic questionnaire. Only patients
were blinded to group assignment. The lidocaine block group received 1 mL of 1% lidocaine
at the tenaculum site and 4.5 mL at 4 o’clock and 8 o’clock at the cervicovaginal junction.
For the sham block, pressure was applied to these same three sites with the unbroken, wood
end of a cotton-tipped applicator to depress the vaginal epithelium 1 mm. There was a 3Obstet Gynecol. Author manuscript; available in PMC 2018 August 22.

Akers et al.

Page 4

Author Manuscript

minute delay after administering the lidocaine and sham block before IUD insertion to allow
onset of action for the lidocaine. IUD insertion followed the manufacturer’s instructions,
including sounding the uterus before inserting the IUD. All devices were inserted by an
experienced provider who was an attending physician or a family planning fellow.
After IUD insertion, clinicians completed a questionnaire assessing procedural details
(uterine size and depth, need for dilation or ultrasound guidance, and adverse events). One
item assessed provider-rated patient anxiety by asking if the patient’s general affect seemed
“pleasant and appropriately engaging” or “anxious”. Following IUD insertion, a postprocedure questionnaire was administered to participants by a research coordinator to rate
their satisfaction with and discomfort during the procedure.

Author Manuscript

Participants who completed all study activities received $50 for their time. Devices were
provided free of charge by the study funder. Participants’ insurance was billed for the
clinical procedure fee. Clinicians were not compensated for performing the IUD insertion
nor for completing the questionnaire.
Outcomes

Author Manuscript

Satisfaction with the IUD insertion procedure was measured using three single-item
satisfaction measures adapted from items commonly used to assess satisfaction with various
dimensions of clinical care. Overall satisfaction was assessed with an item that asked, “How
would you rate your overall satisfaction with your IUD placement?” Response options
ranged from “very dissatisfied” (1) to “very satisfied” (5). Participants were classified as
satisfied if they responded “Very satisfied”. The second item asked if participants would
“recommend an IUD to a friend”. Response options included, “Definitely yes”, “Probably
yes”, “Neutral”, “Probably not”, “Definitely not”, and “Don’t know, No opinion”.
Participants were classified as satisfied if they responded “Definitely yes”. The third item
asked if getting the IUD “was worth the discomfort”. Response options were “Yes”, “No” or
“Unsure”. Higher scores denoted greater satisfaction, higher IUD recommendation, or the
belief that the procedure was worthwhile, respectively.
Covariates

Author Manuscript

Demographic variables included age, race, Hispanic ethnicity, marital status, insurance
status, and education level. Sexual and reproductive history variables included age at
menarche and whether participants had ever been sexually active, pregnant, used hormonal
birth control, had a gynecologic exam, or were currently using birth control. As part of the
medical history, participants completed the 4-item Patient Health Questionnaire-4 (PHQ-4),
which consists of a 2-item depression scale and a 2-item anxiety scale. Scores > 3 suggest
clinical depression or anxiety, respectively.19 The single-item provider-rated anxiety variable
was dichotomous (yes or no). Pain at IUD insertion was recorded using a 100 mm visual
analog scale (VAS). Participants touched a line anchored from “no pain” (0 mm) to “worst
pain in my life” (100 mm) using an iPad at seven time points: baseline (prior to placement in
lithotomy), immediately after speculum placement, tenaculum placement, block
administration, uterine sounding, IUD insertion, and 5-minutes after speculum removal. The
pain score reported immediately after IUD insertion, which was the primary outcome for the
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parent study, was included in the models. Treatment group assignment (paracervical block
versus sham block group) was also included.
Analysis
Between-group differences in the baseline characteristics for the treatment groups were
compared using chi-square test for proportions, Fisher’s exact test for small numbers, and
Wilcoxon rank-sum tests for continuous data that were not normally distributed.

Author Manuscript

Each of the three outcome variables were ordinal and highly skewed, with more than twothirds of participants selecting the highest response category reflecting high overall
satisfaction with the procedure, high likelihood of recommending an IUD to a friend, and a
strong belief that the IUD was worth the discomfort. All three outcomes were therefore
dichotomized to compare the highest response category to all the other response categories
combined. Separate logistic regression models were run for each of the 3 dependent
variables.

Author Manuscript

Predictor variables with small sample sizes (< 10% of respondents per cell) were excluded
from analysis (i.e., Hispanic ethnicity, marital status, ever sexually active, prior pregnancy,
self-reported depression and anxiety, and provider rating of participant’s anxiety). The
variable assessing whether participants had ‘ever used birth control’ was excluded as it was
highly correlated with the variable assessing ‘current birth control use’, which was included.
Age was dichotomized to assess whether younger age (14 to 17 years) or older age (18 to 22
years) was a significant predictor of each outcome. Race was dichotomized as White vs nonWhite. Education level was continuous with higher levels reflecting more education.
Number of prior gynecologic exams and pain scores following IUD insertion were used as
predictors of each outcome as well. ORs and 95% CIs estimates in the multivariable models
were robust to the number of predictors selected.
Two-tailed p-values less than .05 were considered significant. Analyses were completed with
SAS software, version 9.3 (SAS Institute).

RESULTS

Author Manuscript

Of the 95 participants who enrolled in the trial, 93 were included in the outcome analysis.
One was dropped due to missing insurance data and the other due to missing pain score at
IUD insertion. Participant characteristics are shown in Table 1. The mean age of the sample
was 19.4 ± 2.1. Almost half were white (47.4%) and a third were black (36.0%). Most were
ages 18 to 22 years (80.0%), never married (95.8%), had at least some college education
(67.4%), and were privately insured (66.0%). Most also reported having had sex at least
once (91.6%) and prior contraceptive use (79.0%); few reported current contraceptive use
(43.2%) or a prior pregnancy (4.2%). Two-thirds (69.5%) reported having a prior
gynecologic exam; the types of gynecologic exams varied, with 59.0% reporting a prior
visual inspection of the vulva, 51.6% reported a prior bimanual exam, 44.2% reported a
prior speculum exam, and 30.5% reported a prior pap smear.

Obstet Gynecol. Author manuscript; available in PMC 2018 August 22.
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Participants were equally distributed among the treatment groups with 47 randomized to the
paracervical block group and 48 to the sham group (Figure 1). The baseline characteristics
were similar in both groups, except those in the paracervical block group were less likely to
be current contraceptive users compared to those in the sham group (31.9% versus 54.2%,
p=0.03). The median pain score (± interquartile range [IQR]) reported immediately
following IUD insertion for the sample was 63.5±53, with lower scores in the lidocaine
paracervical block group compared to the sham block group (30.0±52, versus 71.5±23.5,
p<0.0001)
Overall Satisfaction with IUD insertion

Author Manuscript

Most participants reported being “very satisfied” with their IUS insertion procedure (n=73,
76.8%), with 14 (14.7%) being “somewhat satisfied”, 6 (6.3%) were “neutral”, 1 (1.1%)
were “somewhat dissatisfied”, and 1 (1.1%) were very dissatisfied. There were no
differences in satisfaction between the lidocaine block group compared to the sham group
(91.5% versus 91.7%, p=0.30).
As shown in Table 2, the odds of reporting higher overall satisfaction were lower among
younger adolescents compared to older adolescents (OR 0.07; 95% Confidence Interval
(CI): 0.008, 0.68); among those who had never had a gynecologic exam compared to those
who had (OR 0.26; 95% CI: 0.069, 0.99); and decreased as the pain score following IUD
insertion increased (OR 0.96; 95% CI: 0.94, 0.99).
Would Recommend an IUD to a Friend

Author Manuscript

When asked if they would recommend an IUD to a friend, 64 (67.4%) said “definitely yes”,
20 (21.1%) “probably yes”, 6 (6.3%) were neutral, 3 (3.2%) “probably low”, and 2 (2.1%)
“definitely no”. There were no differences in recommending an IUD insertion to a friend
among the lidocaine block group compared to the sham group, (91.5% versus 85.4%,
p=0.45). As shown in Table 2, the odds of recommending an IUD to a friend decreased as
the pain score following IUD insertion increased (OR 0.96, 95% CI: 0.941–0.986). Odds of
recommending an IUD to a friend were lower among those who had never had a
gynecologic exam compared to those who had, but this did not reach statistical significance
(OR 0.32; 95% CI: 0.10, 1.01).
IUD was Worth the Discomfort

Author Manuscript

Most participants endorsed that getting the IUD was “worth the level of discomfort” (n=79,
83.2%), none reported that it was “not worth the level of discomfort” and 16 (16.8%) were
“unsure at this time”. There were no differences between the lidocaine block group
compared to the sham group (44.2% versus 39.0%, p=0.11). As shown in Table 2, the odds
of reporting that getting the IUD was worth the discomfort decreased as the pain score
following IUD insertion increased (OR 0.96, 95% CI: 0.93–0.99).

DISCUSSION
Utilization of IUDs is low among adolescents and young adult women, in part due to fears
regarding discomfort during the insertion process.7,8,12 In this secondary data analysis study,
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we examined three dimensions of satisfaction with the IUD insertion procedure among
adolescent and young adult women. We found that the majority of young women reported
high satisfaction with the IUD insertion procedure. Eight of ten women reported high overall
satisfaction with the procedure and believed the procedure was worth the discomfort they
experienced. Seven of 10 would recommend an IUD to a friend. Higher pain during IUD
insertion was the only variable associated with lower odds of satisfaction with the procedure
on all 3 satisfaction measures.
Patient satisfaction is an important aspect of evaluating the quality of healthcare services,
20,21 with pain management increasingly recognized as being highly correlated with
satisfaction.20 Few studies have examined associations between pain management and
patient satisfaction with procedures performed in outpatient clinic settings. This study
therefore fills an important gap.

Author Manuscript
Author Manuscript

Our finding that higher pain during the IUD insertion procedure was the only variable
consistently associated with reduced odds of satisfaction with the IUD insertion procedure
suggests that pain-reduction interventions may be important for young women. Moreover,
the finding that younger adolescents and those with no prior gynecologic exam were less
likely to be satisfied with the IUD insertion procedure suggests that patients with these
characteristics, in particular, may derive benefit from routine use of a paracervical block,
other interventions designed to enhance procedure tolerance, or the opportunity to undergo
IUD placement under sedation. In the current study, a 10 mL paracervical block with 1%
lidocaine was used. Future studies should consider examining the effectiveness of other pain
control interventions that are currently understudied in this population, including the 4-site
paracervical block, lidocaine spray or gel applied to the cervix prior to placing a paracervical
block, or using a higher dose of a lidocaine paracervical block.
We found no differences in patient satisfaction in the sham block group and paracervical
block group despite the sham group reporting significantly more pain with the procedure.
Similar to our study, prior randomized controlled trials assessing the effectiveness of various
pain medications in reducing pain during IUD insertion have consistently noted high rates of
satisfaction with the IUD insertion procedure, regardless of the pain control regimen used.
22–24 None of these studies, including our current study, assessed how motivated women
were to have an IUD placed. Patients who are highly motivated to get an IUD may report
high satisfaction due to receiving the contraceptive method of their choice, despite
experiencing pain during the insertion procedure. Assessing young women’s motivations for
using an IUD is an under-explored area that may be important for better understanding the
relationship between patient satisfaction and reported pain.

Author Manuscript

There are a number of limitations in the current study. Although there are 4 hormonal IUDs
on the market, we examined satisfaction with insertion of only the 13.5 mg levonorgestrel
13.5 mg IUD; these findings may not extend to other types of IUDs. We only examined
satisfaction immediately following the IUD insertion, but patient satisfaction might change
over time. In particular, participants’ perception that going through the IUD insertion
process was worth the discomfort and their willingness to recommend an IUD to a friend
might change depending on their experience with the method over time. Another key
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limitation was that our study was powered to assess pain control, not patient satisfaction. It
is possible that had we powered the study to assess patient satisfaction, we may have seen
different results. Young age (age 14 – 17 years) was noted to be associated with decreased
overall satisfaction, but the small size of this group (less than a quarter of analyzed
participants) likely limited subgroup analyses by age. Finally, there are some predictors that
may influence patient satisfaction that we could not analyze due to too few of our subjects
reporting those predictors. If we had a larger sample size, predictors such as anxiety or
depression may have influenced patient satisfaction.

CONCLUSION

Author Manuscript

Adolescents and young women report high overall satisfaction with the IUD insertion
procedure, whether or not they receive a paracervical block. Although younger age, lack of
experience with a gynecologic exam, and higher pain were inversely associated with
satisfaction, most young women consider receiving an IUD to be worth the discomfort.
Future research should evaluate satisfaction with the IUD over a longer time period, as well
as other interventions to improve the IUD insertion experience for younger adolescents.
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Characteristics of Participants, by treatment group (N=95)
Total Sample (N=95)
n (%)

Block Group (N= 47)
n (%)

Sham Group (N= 48)
n (%)

19.4±2.1

19.3±2.1

19.5±2.1

Ages 14 – 17 years

19 (20.0)

10 (18.8)

9 (18.8)

Ages 18 – 22 years

76 (80.0)

37 (78.7)

39 (81.3)

White

45 (47.4)

15 (31.9)

19 (39.6)

Black

34 (36.0)

23 (48.9)

22 (45.8)

Other

16 (16.8)

9 (19.2)

7 (14.6)

86 (90.5)

42 (89.4)

44 (91.7)

91 (95.8)

46 (97.9)

45 (93.8)

Never married, living with partner

3 (3.2)

1 (2.1)

2 (4.2)

Married, living with partner

1 (1.1)

0 (0.0)

1 (2.1)

22 (23.2)

11 (23.4)

11 (22.9)

Covariates
Mean age in years ± SD1
Age group

Primary Race

Author Manuscript

% Non-Hispanic
Marital Status
Never married, not living with partner

Education
Less than high school degree
High school degree or equivalent

9 (9.5)

5 (10.6)

4 (8.3)

64 (67.4)

31 (66.0)

33 (68.8)

1 (1.1)

0

1 (2.1)

Public insurance

29 (30.9)

15 (32.6)

14 (29.2)

Private insurance

62 (66.0)

30 (65.2)

32 (66.7)

2 (2.1)

1 (2.2)

1 (2.1)

Age at menarche in years ±SD

11.9±1.6

11.7±1.7

12.1±1.5

Ever sexually active

87 (91.6)

44 (93.6)

43 (89.6)

4 (4.2)

2 (4.3)

2 (4.2)

Ever used hormonal birth control

75 (79.0)

37 (78.7)

38 (79.2)

Currently using hormonal birth control

41 (43.2)

15 (31.9)

26 (54.2)

Prior gynecologic exam

Some college or higher
Insurance
None

Author Manuscript

None or other

Prior pregnancy

Author Manuscript

66 (69.5)

34 (72.3)

32 (66.7)

Median number of prior gynecologic exams ±IQR2

2.0±3.0

2.0±3.0

2.0±3.0

% Clinically anxiety

2 (2.1)

1 (2.1)

1 (2.1)

% Clinically depressed

2 (2.1)

2 (4.26)

0 (0.0)

% Provider-rated participant anxiety

9 (9.5)

5 (10.6)

4 (8.3)

1

SD=standard deviation

2

Interquartile range (IQR)
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Author Manuscript
0.56 (0.21 – 1.49)
1.62 (1.03 – 2.53)
0.50 (0.19 – 1.34)
1.19 (0.87 – 1.61)
1.84 (0.70 – 4.84)
0.57 (0.21 – 1.53)
1.90 (0.71 – 5.10)
0.97 (0.95 – 0.99)

Race: Non-white (ref: White)

Education level

Insurance: Non-private (ref: Private)

Age at menarche

Current birth control user: no (ref: Yes)

Prior gynecologic exam: no (ref: Yes)

Randomization group: Block (ref: sham)

Pain at IUD insertion

0.96 (0.94 – 0.99)

1.14 (0.33 – 4.01)

0.26 (0.07 – 0.99)

1.57 (0.49 – 5.05)

0.93 (0.62 – 1.39)

1.03 (0.20 – 5.29)

0.67 (0.31 – 1.48)

0.99 (0.22 – 4.49)

0.07 (0.008 – 0.68)

aOR

0.97 (0.96 – 0.99)

1.80 (0.75 – 4.34)

0.60 (0.24 – 1.49)

0.94 (0.39 – 2.24)

1.31 (0.86 – 1.48)

1.34 (0.53 – 3.42)

0.99 (0.67 – 1.42)

1.30 (0.55 – 3.07)

1.15 (0.38 – 3.26)

0.97 (0.94 – 0.99)

2.38 (0.76 – 7.50)

0.99 (0.31 – 3.18)

1.91 (0.64 – 5.66)

1.19 (0.84 – 1.67)

1.12 (0.35 – 3.57)

1.13 (0.71 – 1.79)

1.54 (0.52 – 4.57)

0.73 (0.21 – 2.57)

Crude OR

0.96 (0.93 – 0.99)

0.89 (0.22 – 3.57)

0.56 (0.14 – 2.24)

1.50 (0.41 – 5.40)

1.27 (0.81 – 1.99)

0.99 (0.14 – 7.15)

0.95 (0.40 – 2.12)

4.07 (0.68 – 24.34)

0.66 (0.07 – 6.20)

aOR

Worth the Discomfort
Yes: n=79 (83.2%)
Unsure: n=14 (16.8%)

Data are OR and 95% confidence intervals, unless otherwise specified

Covariates included in models: age group, race, education level, insurance, number of prior gynecologic exams, randomization block group, current birth control user, and pain score following IUD
insertion.

0.96 (0.94 – 0.99)

0.80 (0.26 – 2.45)

0.32 (0.10 – 1.01)

0.66 (0.23 – 1.92)

1.31 (0.90 – 1.91)

1.16 (0.26 – 5.13)

0.77 (0.40 – 1.49)

2.8 (0.71 – 10.58)

0.76 (0.12 – 4.99)

aOR

Recommend to Friend
Definitely yes: n=64 (67.4%)
Other: n=29 (32.6%)
Crude OR

Abbreviations: CI=confidence interval; OR=odds ratio; aOR= adjusted OR; ref=referent group

0.24 (0.08 – 0.70)

Crude OR

Overall Satisfaction
Very satisfied: n=73 (76.8%)
Other: n=20 (73.2%)

Age 14 – 17 years (ref: 18 – 22 years)

Covariates

Odds of reporting high overall satisfaction with the IUD procedure, recommending an IUD to a friend, and perceiving the IUD procedure was worth the
pain from multivariable logistic regression (N=93)
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